ClearPoint Neuro, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $21.3M | $2.4M | $20.1M |
| FY2021 | $9.8M | $48.8M | $54.1M |
| FY2022 | $9.9M | $36.9M | $27.6M |
| FY2023 | $9.9M | $21.2M | $23.1M |
| FY2024 | — | $25.4M | $20.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $21.3M | $2.4M | $20.1M |
| FY2021 | $9.8M | $48.8M | $54.1M |
| FY2022 | $9.9M | $36.9M | $27.6M |
| FY2023 | $9.9M | $21.2M | $23.1M |
| FY2024 | — | $25.4M | $20.1M |